Stocky turns companies like Ironwood Pharmaceuticals, Inc. into a fun, safe way to learn investing — a virtual portfolio, live scores & charts, and real analyst data, with no real money.
Try Stocky free →Ironwood Pharmaceuticals, Inc.'s latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 6 Aug 2026Investors learn how the company performed financially in the three months ending June 30, 2026.
More shares available for employee compensation could dilute existing shareholders' ownership percentages.
Company eliminated a major loan obligation using cash, reducing financial risk and obligations.
Leadership changes affect how the company is managed and controlled.
CFO departures signal potential management transitions that may affect company operations.
Investors learn how the company performed financially in the three months ending March 31, 2026.
Investors learn how the company performed financially in the three months ending March 31, 2026.
Stocky reads Ironwood Pharmaceuticals, Inc.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
Ironwood Pharmaceuticals, Inc.'s most recent tracked filing was a 8-K on 6 Aug 2026: Shares second quarter 2026 business update and results.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
This page is just a preview. Open the live, interactive version for the full picture:
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 6 Aug 2026.